Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
December 30, 2010 3:33 PM 5 min read

Earnings Scorecard: CarMax - Analyst Blog

by Zacks Benzinga Contributor
Follow

CarMax Inc. (KMX) reported its earnings for the third quarter of its fiscal year 2011, ended November 30, 2010, on December 21, 2010, barely surpassing the Zacks Consensus Estimate by 2 cents per share. However, the market reacted negatively, with share prices falling subsequent to the earnings release due to the weak performance of CarMax Auto Finance and absence of the company's outlook.

Analysts were indifferent as well, without upgrading or downgrading the stock since the earnings announcement. Below we will cover the results of the recent earnings announcement, subsequent analyst estimate revisions and Zacks ratings for both short-term and the long-term.

Third Quarter Highlights

CarMax has beaten the Zacks Consensus Estimate with the help of a rebound in customer traffic and sales execution along with a favorable year-over-year comparison. This was reflected in the improvement of comparable store sales by 16% for the quarter.

Net sales and operating revenues in the quarter went up 23% to $2.12 billion, higher than the Zacks Consensus Estimate of $1.97 billion. Used vehicle sales escalated 20% to $1.69 billion while new vehicle sales rose 24.9% to $47.7 million.

Gross profit was $297.9 million in the quarter, up 23% from $242.9 million driven by increases in used and wholesale unit sales as well as an improvement in ESP revenues.

CAF reported a decline in income to $55.7 million from $65.8 million in the quarter. The lower income was attributable to adjustments of $31.6 million related to loans originated in the third quarter of previous fiscal year.

In the first nine months of fiscal 2011, CarMax had a cash outflow of $22.5 million compared with an inflow of $56.5 million in the same period of the prior year. The decline in cash flow was mainly attributable to increases in inventory and auto loans receivables.

(Read our full coverage on this earnings report:  CarMax Surpasses Zacks Estimates)

Earnings Estimate Revisions – Overview

Estimates have remained the same over the last 7 days, reflecting analysts' indifference about the stock, driven by the lackluster results of the company and absence of any earnings outlook. Let us delve into the earnings estimate details.

Agreement of Estimate Revisions

The table below shows a strong agreement among analysts regarding the outlook of CarMax's earnings. Over the last 7 days, none of the analysts covering the stock have revised the estimate for both fiscal 2011 and 2012.

However, over the last 30 days, 6 out of 14 analysts covering the stock have revised the estimate upward for fiscal 2011 while 2 analysts moved in a downward direction. For fiscal 2012, 9 out of 14 analysts have revised the estimate upward while only one moved it downward.

Magnitude of Estimate Revisions

Earnings estimate for fiscal 2011 has remained the same at $1.64 since the earnings announcement. It has been revised upward 30 days ago from $1.61. The trend is same for fiscal 2012. Analysts have revised upward the estimate 30 days ago by 6 cents to $1.77. However, no revisions were made over the last 7 days.

CarMax in Neutral Lane

CarMax's strong exposure to the used-car market has helped it improve the results through a favorable appraisal buy rate. The automotive retailer's car-buying appraisal strategy helps provide an inventory of makes and models that reflects the tastes of each market.

The improved economic and sales environment in the U.S. has helped CarMax to resume its strategy to open new used-car superstores every year. Under the strategy (suspended at the end of fiscal year 2009) the company plans to open used-car superstores at an annual rate of 15%–20% of its used-car superstore base every year.

During the first half of fiscal 2011, the company opened one used-car superstore, entering the Augusta, Georgia market. Subsequent to the end of the quarter, it has also opened the two remaining new stores in Cincinnati and Dayton, Ohio. It now plans to open five stores in 2012; and five to ten in 2013. However, the decline in cash flow may hamper the company's aggressive store expansion strategy.

However, slow sales in the new vehicle market, especially domestic cars, have forced manufacturers and dealers to offer incentives and attractive pricing for new cars. These have encouraged consumers to trade in their old cars for new, which has lowered used-car sales and increased the used-car inventory. This is forcing CarMax to lower the prices of vehicles in order to reduce a high used-car inventory, thereby shrinking margins.

Due to the above factors, CarMax retains a Zacks #3 Rank (Hold) on its stock for the short term (1–3 months) and we have reiterated our long-term recommendation of Neutral for the long term (more than 6 months).

About Earnings Estimate Scorecard



CARMAX GP (CC
) (
KMX
): Free Stock Analysis Report


Zacks Investment Research
Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
Automotive RetailConsumer Discretionary
CC Logo
CCThe Chemours Co
$20.70-2.15%
Overview
KMX Logo
KMXCarMax Inc
$44.75-1.97%

Len Zacks, PhD in mathematics from MIT, proved over 30 years ago that earnings estimate revisions are the most powerful force impacting stock prices. He turned this ground breaking discovery into two of the most celebrating stock rating systems in use today. The Zacks Rank for stock trading in a 1 to 3 month time horizon and the Zacks Recommendation for long-term investing (6+ months). These “Earnings Estimate Scorecard” articles help analyze the important aspects of estimate revisions for each stock after their quarterly earnings announcements. Learn more about earnings estimates and our proven stock ratings athttp://www.zacks.com/education/

CC Logo
CCThe Chemours Co
$20.70-2.15%
Overview
KMX Logo
KMXCarMax Inc
$44.75-1.97%
Comments
Loading...